SNCA and Alzheimer disease: The aggregation propensity of α-synuclein and its involvement in neurodegenerative diseases had already been reported, albeit without being recognised as α-synuclein, as it had previously been associated with the non-amyloid component of plaques in AD patients [234], who frequently develop Lewy bodies [109,235].